Reviewed: 2026-04-16 · By the Peptide Protocol editorial team
A ranking of peptides used to accelerate soft-tissue healing, tendon and ligament recovery, and post-training repair. Ordered by quality of evidence in 2026 — heavy preclinical signal, lighter human-trial backing, with the gap flagged at every step.
A note on evidence quality: recovery peptides have strong animal and anecdotal data but limited controlled human trials. This ranking reflects evidence available, not evidence we'd like to have. If your injury is structural, imaging and physical therapy beat any peptide.
The short version
BPC-157 — the most-studied recovery peptide in animal models; strong anecdotal human use for tendon, ligament, and GI repair.
TB-500 — thymosin-β4 fragment; systemic healing, commonly stacked with BPC-157.
GHK-Cu — copper tripeptide with real human skin and wound-healing data.
IGF-1 LR3 — direct anabolic signal; faster tissue remodeling but systemic risks.
CJC-1295 + Ipamorelin — indirect support via GH/IGF-1 axis for overall recovery capacity.
1.
BPC-157
ClassGastric pentadecapeptide
Recovery effectTendon, ligament, muscle, and GI healing in preclinical models
FDANot approved; research-use only
CadenceDaily subcutaneous or targeted injection
BPC-157 has the largest preclinical evidence base of any recovery peptide. Dozens of animal studies show accelerated healing across tendon transection, Achilles rupture, muscle crush, and colitis models. Controlled human trials are essentially absent, but the safety signal in animals is clean and the anecdotal reports from athletes and injured patients are consistent.
Strengths
Largest preclinical dataset of any healing peptide
Broad tissue coverage — tendon, muscle, gut, skin
Oral formulations are being tested
Favorable animal safety profile
Trade-offs
No controlled human trials
FDA added to 503A/B restricted list in 2023
Dosing conventions derived from body-weight scaling animal studies
Research-chem supply quality varies
Pair with:TB-500 for soft-tissue injuries or GHK-Cu for connective-tissue and skin.
2.
TB-500 (Thymosin β4 fragment)
ClassSynthetic fragment of thymosin β4
Recovery effectActin sequestration → cell migration and angiogenesis in wound sites
FDANot approved (full-length Tβ4 was trialed as RGN-259)
CadenceWeekly or twice-weekly subcutaneous injection
TB-500 is a synthetic analog of the actin-binding region of thymosin β4. Full-length thymosin β4 has had legitimate human trials for corneal and dermal wound healing. TB-500 itself is an unapproved derivative that relies on those trials and a handful of equine veterinary studies for its case. It's almost always run alongside BPC-157.
Strengths
Related molecule has human wound-healing data
Long half-life — weekly dosing works
Synergistic with BPC-157 in animal models
Equine veterinary adoption is extensive
Trade-offs
TB-500 itself has no controlled human data
Confusion with full-length Tβ4 oversells the evidence
FDANot approved as a drug; widely used in cosmetic dermatology
CadenceTopical or subcutaneous; daily
GHK-Cu has the cleanest evidence base on this list — decades of peer-reviewed dermatology and wound-healing data, including human clinical trials on topical formulations for skin repair, aging, and hair regrowth. For skin and connective-tissue recovery, it beats everything above it. For deep tendon or ligament injuries, the mechanism fits less well.
Strengths
Extensive human dermatology and wound-healing literature
Topical and injectable routes both work
Clean side-effect profile
Strong collagen-synthesis mechanism
Trade-offs
Evidence strongest for skin, weaker for tendon/ligament
Copper accumulation a theoretical risk at high doses
Injection site reactions common
4.
IGF-1 LR3
ClassLong-acting IGF-1 analog (R3 substitution + N-terminal extension)
Recovery effectDirect anabolic signaling — muscle hypertrophy and satellite-cell activation
FDANot approved; mecasermin (native IGF-1) is approved for specific pediatric indications
CadenceDaily subcutaneous injection
IGF-1 LR3 is the most potent anabolic signal on this list — it bypasses IGF-1-binding proteins and produces a longer-lasting, higher-magnitude effect than native IGF-1. That potency also makes it the riskiest. For localized post-injury recovery it can shorten healing timelines; for general "recovery" it's excessive and the systemic risks (hypoglycemia, tumor growth signals, sustained mitogenic signaling) outweigh the benefit.
Strengths
Strongest direct anabolic signal of any peptide
Localized site-injection protocols exist
Real human IGF-1 pharmacology underpins the mechanism
Site injection protocols are not well-standardized
Concerns about occult tumor promotion
5.
CJC-1295 + Ipamorelin
ClassGHRH analog + selective GHRP
Recovery effectIndirect — augments nocturnal GH pulse and downstream IGF-1
FDANot approved
CadenceDaily subcutaneous, usually pre-bed
This stack is a support player in the recovery context, not a primary. It doesn't accelerate tendon healing directly; it raises the substrate — endogenous GH and IGF-1 — that tissue repair relies on. For general training recovery, sleep quality, and slower but safer tissue remodeling, it's a reasonable adjunct to BPC-157 or GHK-Cu rather than a standalone.
Strengths
Supports recovery via physiological GH/IGF-1 pathways
Favorable long-term profile vs. direct IGF-1 LR3
Sleep and recovery effects often reported together
Trade-offs
Indirect effect — slower timelines
Daily injection commitment
Not a localized injury tool
What this list leaves out
MGF (Mechano Growth Factor) — splice variant of IGF-1 marketed for localized muscle repair. Mechanism is real but the commercial peptide is unstable and product identity across research-chem supply is unreliable.
Follistatin-344 — myostatin inhibitor used anecdotally for muscle growth and recovery. Effect size in humans is uncertain; safety in long-term use is unstudied.
LL-37 / KPV — peptides with real immunomodulatory and wound-healing mechanisms, but the injury-recovery use case is much less studied than their inflammatory-bowel context.
HGH / Tesamorelin — raise IGF-1 reliably, but are not targeted recovery tools; the side-effect and cost burden rarely justifies use for recovery alone.
Before you decide anything
None of the peptides on this list are FDA-approved for recovery, injury, or performance. If you have an acute injury, imaging and a sports-medicine consult come first — peptides do not repair torn tissue that needs surgical intervention. If you're using these in-competition, check the WADA prohibited list: BPC-157, TB-500, and IGF-1 LR3 are all banned. See our medical review process for how we evaluate this content.
Track your protocol on iPhone
Peptide Protocol logs every dose, tracks side effects, and lets you mark injury milestones — so you can see which compounds are actually moving your recovery.
Educational use only. Nothing on this page constitutes medical advice or a recommendation to use any specific peptide. Recovery-related peptide decisions should be made with a licensed healthcare professional who has evaluated your injury.
